KALIPOZ PROLONGATUM [Kalio chloridas GSK]

Medicinal product

(Invented) name

KALIPOZ PROLONGATUM [Kalio chloridas GSK]

Active substance (s)

Kalio chloridas

Strength

750 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A12BA01, Potassium chloride

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2024-09-23

Date of renewal

Documents

2219_KALIPOZ PROLONGATUM [Kalio chloridas GSK]_2025-01-13_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Kalio chloridas	750 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115084	101194	1101194	lizdinė plokštelė	N20		Receptinis	LT/L/24/2219/001	Netiekiama	-	-	No	-	-
115085	101195	1101195	lizdinė plokštelė	N30		Receptinis	LT/L/24/2219/002	Netiekiama	-	-	No	-	-	Download
115086	101196	1101196	lizdinė plokštelė	N40		Receptinis	LT/L/24/2219/003	Netiekiama	-	-	No	-	-
115087	101197	1101197	lizdinė plokštelė	N60		Receptinis	LT/L/24/2219/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-09-23	Registruotas